Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Cash from Financing Activities (2019 - 2025)

Outset Medical (OM) has disclosed Cash from Financing Activities for 7 consecutive years, with $231000.0 as the latest value for Q3 2025.

  • Quarterly Cash from Financing Activities rose 90.91% to $231000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $55.5 million through Dec 2025, down 18.22% year-over-year, with the annual reading at $55.5 million for FY2025, 18.22% down from the prior year.
  • Cash from Financing Activities for Q3 2025 was $231000.0 at Outset Medical, up from -$384000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $150.8 million in Q2 2021, with the low at -$938000.0 in Q4 2024.
  • Average Cash from Financing Activities over 5 years is $21.1 million, with a median of $2.5 million recorded in 2022.
  • The sharpest move saw Cash from Financing Activities skyrocketed 558448.15% in 2021, then plummeted 598.7% in 2025.
  • Over 5 years, Cash from Financing Activities stood at $934000.0 in 2021, then skyrocketed by 6923.55% to $65.6 million in 2022, then plummeted by 49.35% to $33.2 million in 2023, then plummeted by 102.82% to -$938000.0 in 2024, then surged by 124.63% to $231000.0 in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $231000.0, -$384000.0, and $55.7 million for Q3 2025, Q2 2025, and Q1 2025 respectively.